The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma DOI Open Access

Guojie Lei,

Lusheng Tang,

Yanhua Yu

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2023, Volume and Issue: 167, P. 115522 - 115522

Published: Sept. 25, 2023

Renal cell carcinoma (RCC) is one of the top ten malignancies and tumor-related causes death worldwide. The most common histologic subtype kidney renal clear (KIRC), accounting for approximately 75% all RCC cases. Early resection considered basic treatment patients with KIRC. However, 30% these experience recurrence post-operation. Cuproptosis, an autonomous mechanism controlling death, encompasses various molecular mechanisms multiple cellular metabolic pathways. These pathways mainly include copper signaling pathways, mitochondrial metabolism lipoic acid pathway Recent evidence shows that cuproptosis identified as a key modality plays meaningful role in tumor progression. there no published systematic review summarizes correlation between KIRC, despite fact investigations on pathogenesis KIRC have increased past years. Researchers discovered exogenous infusion accelerates dysfunction suppresses cells by inducing cuproptosis. levels tricarboxylic cycle proteins, protein, copper, ferredoxin 1 (FDX1) were dysregulated cells, prognosis high FDX1 expression better than low expression. Cuproptosis played indispensable regulation microenvironment features, progression, long-term In this review, we summarized systemic processes copper-related highlighting potential targets related to treatment.

Language: Английский

Copper homeostasis and cuproptosis in cancer immunity and therapy DOI Open Access

Wei‐Qing Liu,

Wanrong Lin, Yan Li

et al.

Immunological Reviews, Journal Year: 2023, Volume and Issue: 321(1), P. 211 - 227

Published: Sept. 16, 2023

Summary Copper is an essential nutrient for maintaining enzyme activity and transcription factor function. Excess copper results in the aggregation of lipoylated dihydrolipoamide S‐acetyltransferase (DLAT), which correlates to mitochondrial tricarboxylic acid (TCA) cycle, resulting proteotoxic stress eliciting a novel cell death modality: cuproptosis. Cuproptosis exerts indispensable role cancer progression, considered promising strategy therapy. Cancer immunotherapy has gained extensive attention owing breakthroughs immune checkpoint blockade; furthermore, cuproptosis strongly connected modulation antitumor immunity. Thus, thorough recognition concerning mechanisms involved metabolism may facilitate improvement management. This review outlines cellular molecular characteristics links regulated modality with human cancers. We also current knowledge on complex effects immunity response. Furthermore, potential agents that elicit pathways are summarized. Lastly, we discuss influence induction tumor microenvironment as well challenges adding regulators therapeutic strategies beyond traditional

Language: Английский

Citations

56

METTL3: a multifunctional regulator in diseases DOI
Na Li, Wei Xiang,

J.J. Dai

et al.

Molecular and Cellular Biochemistry, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 24, 2025

Language: Английский

Citations

2

Targeting copper metabolism: a promising strategy for cancer treatment DOI Creative Commons

Ruimin Kong,

Guojuan Sun

Frontiers in Pharmacology, Journal Year: 2023, Volume and Issue: 14

Published: July 26, 2023

Copper is an essential micronutrient that plays a critical role in many physiological processes. However, excessive copper accumulation cancer cells has been linked to tumor growth and metastasis. This review article explores the potential of targeting metabolism as promising strategy for treatment. Excessive associated with By disrupting homeostasis inducing cell death through copper-dependent mechanisms (cuproplasia cuprotosis, respectively), therapies can be developed improved efficacy reduced side effects. The discusses biological processes, such angiogenesis, immune response, redox homeostasis. Various approaches treatment are examined, including use enzymes, copper-based compounds, cuprotosis-related genes or proteins. also strategies like chelation therapy nanotechnology targeted delivery copper-targeting agents. understanding intricate network cuprotosis its interactions microenvironment system, new targets identified, leading outcomes. Overall, this comprehensive highlights significant effective approach treatment, while providing valuable insights into current state research field.

Language: Английский

Citations

27

Comprehensive bioinformatics analysis reveals the role of cuproptosis-related gene Ube2d3 in myocardial infarction DOI Creative Commons
Ming Yang, Yucheng Wang,

Liming He

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Feb. 19, 2024

Background Myocardial infarction (MI) caused by severe coronary artery disease has high incidence and mortality rates, making its prevention treatment a central challenging aspect of clinical work for cardiovascular practitioners. Recently, researchers have turned their attention to novel mechanism cell death Cu 2+ , cuproptosis. Methods This study integrated data from three MI-related bulk datasets downloaded the Gene Expression Omnibus (GEO) database, identified 16 differentially expressed genes (DEGs) related cuproptosis taking intersection 6378 DEGs obtained differential analysis with 49 cuproptosis-related genes. Four hub genes, Dbt, Dlat, Ube2d1 Ube2d3, were screened out through random forest Lasso analysis. In group, showed low expression, while Ube2d3 exhibited expression. Results Focusing on subsequent functional studies, we confirmed expression in MI group qRT-PCR Western Blot detection after successful construction mouse model left anterior descending (LAD) ligation, further clarified correlation development detecting levels proteins. Moreover, vitro experiments, was be highly oxygen-glucose deprivation (OGD)-treated cardiomyocytes AC16. order clarify role knocked down OGD-treated AC16 cells, Ube2d3’s promoting hypoxia damage cells inducing cuproptosis, as evidenced MTT, TUNEL, LDH release Conclusion summary, our findings indicate that regulates affect progression MI.

Language: Английский

Citations

13

The copper transporter, SLC31A1, transcriptionally activated by ELF3, imbalances copper homeostasis to exacerbate cisplatin-induced acute kidney injury through mitochondrial dysfunction DOI

Zhimin Qiu,

Qicen Liu,

Ling Jia Wang

et al.

Chemico-Biological Interactions, Journal Year: 2024, Volume and Issue: 393, P. 110943 - 110943

Published: March 9, 2024

Language: Английский

Citations

13

Mechanisms of cuproptosis and its relevance to distinct diseases DOI

Qiao-mei Lou,

Feifan Lai,

Jingwei Li

et al.

APOPTOSIS, Journal Year: 2024, Volume and Issue: 29(7-8), P. 981 - 1006

Published: June 2, 2024

Language: Английский

Citations

12

Ferroptosis in organ ischemia–reperfusion injuries: recent advancements and strategies DOI

Xiaoyu Luan,

Peng Chen, Longyu Miao

et al.

Molecular and Cellular Biochemistry, Journal Year: 2024, Volume and Issue: unknown

Published: March 31, 2024

Language: Английский

Citations

11

Butyrate inhibits the malignant biological behaviors of breast cancer cells by facilitating cuproptosis-associated gene expression DOI Creative Commons
Liming Zhang,

Shan Huang,

Ying Yuan

et al.

Journal of Cancer Research and Clinical Oncology, Journal Year: 2024, Volume and Issue: 150(6)

Published: June 4, 2024

Abstract Background Butyrate is a common short-chain fatty acids (SCFA), and it has been demonstrated to regulate the development of breast cancer (BC), while underlying mechanism still unreported. Methods Gas chromatography was used measure amounts SCFA (acetate, propionate, butyrate) in feces. Cell viability measured by CCK-8 assay. The wound healing assay cell migration, transwell invasion. levels protein gene were determined western blot RT-qPCR assay, respectively. Results lower faecal samples from BC patients compared control samples. In cellular experiments, butyrate significantly suppressed viability, migration invasion T47D dose-dependent manner. animal effectively impeded growth tumors. Toll like receptor 4 (TLR4) highly expressed tumors patients. inhibited expression TLR4. addition, promoted cuproptosis-related genes including PDXK (pyridoxal kinase) SLC25A28 (solute carrier family 25 member 28), which lowly Importantly, overexpression TLR4 can reverses promotion prevention malignant biological behaviors cells. Conclusion summary, inhibits facilitating through inhibition Our investigation first identified connection among butyrate, progression. These findings may provide novel target for treatment BC.

Language: Английский

Citations

9

MiRNA expression profiling and clinical implications in prostate cancer across various stages DOI Creative Commons

Zhengjie Xiang,

Tao Lin,

Jian Ling

et al.

Scientific Reports, Journal Year: 2025, Volume and Issue: 15(1)

Published: March 5, 2025

Abstract This study aims to screen and identify microRNA (miRNA) expression profiles across different stages of prostate cancer (PCa) benign prostatic hyperplasia (BPH) using high-throughput sequencing. The seeks determine whether specific miRNAs show consistent differential various PCa, with the goal identifying potential biomarkers relevant disease progression. In this study, a total 12 specimens PCa BPH were collected from September 2021 June 2022 in Second Affiliated Hospital Nanchang University, 330,006, P.R. China (including 3 early localized tumor, local invasion, distant metastasis tumor BPH). profile miRNA was screened by sequencing technology, differentially expressed between each group bioinformatics analysis. Further targeted site analysis GO enrichment KEGG miRNA-derived genes performed on above miRNAs. Finally, hsa-miR-6715b-3p tissues verified qRT-PCR assay. A 1526 identified through By comparing groups, 228 identified, 100 upregulated 128 downregulated. Additionally, 69 novel predicted. results showed that highly compared tissues. presents preliminary investigation identifies as promising biomarker for Our findings validate high highlight its role critical oncogenic pathways. These provide theoretical foundation further functional studies explore clinical utility therapy resistance progression, contributing growing knowledge miRNA-based PCa.

Language: Английский

Citations

1

Micronutrients/miRs/ATP networking in mitochondria: Clinical intervention with ferroptosis, cuproptosis, and calcium burden DOI
Siva Prasad Panda, Adarsh Kesharwani

Mitochondrion, Journal Year: 2023, Volume and Issue: 71, P. 1 - 16

Published: May 11, 2023

Language: Английский

Citations

18